Treatment of adenoviral conjunctivitis with topical cidofovir.

Suppr

超能文献

作者信息

Gordon Y J, Naesens L, DeClercq E, Maudgal P C, Veckeneer M

出版信息

Cornea. 1996 Sep;15(5):546. doi: 10.1097/00003226-199609000-00018.

DOI:10.1097/00003226-199609000-00018

PMID:8862935

Abstract

摘要

相似文献

Treatment of adenoviral conjunctivitis with topical cidofovir.

Cornea. 1996 Sep;15(5):546. doi: 10.1097/00003226-199609000-00018.

The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.

Ophthalmology. 2002 May;109(5):845-50. doi: 10.1016/s0161-6420(02)00992-2.

Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.

Arch Ophthalmol. 2001 Oct;119(10):1487-91. doi: 10.1001/archopht.119.10.1487.

Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.

Invest Ophthalmol Vis Sci. 1997 Jan;38(1):253-7.

Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):158-62.

Recurrent iritis after intravenous administration of cidofovir.

Clin Infect Dis. 1997 Aug;25(2):337-8. doi: 10.1086/516916.

[Prospects for therapy and prevention of adenovirus keratoconjunctivitis].

Ophthalmologe. 2001 Oct;98(10):991-1007; quiz 1008-9. doi: 10.1007/s003470170052.

Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model.

Antiviral Res. 2001 Dec;52(3):275-80. doi: 10.1016/s0166-3542(01)00166-8.

Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis.

Arch Ophthalmol. 1997 Jun;115(6):801-2. doi: 10.1001/archopht.1997.01100150803021.

Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.

Clin Infect Dis. 1999 Mar;28(3):690-1. doi: 10.1086/517222.

引用本文的文献

Antiviral Drugs in Adenovirus-Induced Keratoconjunctivitis.

Microorganisms. 2022 Oct 12;10(10):2014. doi: 10.3390/microorganisms10102014.

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.

Cochrane Database Syst Rev. 2022 Mar 3;3(3):CD013520. doi: 10.1002/14651858.CD013520.pub2.

Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions.

Clin Ophthalmol. 2020 Mar 17;14:837-852. doi: 10.2147/OPTH.S207976. eCollection 2020.

Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Dtsch Arztebl Int. 2011 Jul;108(27):475-80. doi: 10.3238/arztebl.2011.0475. Epub 2011 Jul 8.

Treatment of viral conjunctivitis with antiviral drugs.

Drugs. 2011 Feb 12;71(3):331-47. doi: 10.2165/11585330-000000000-00000.

Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model.

BMC Ophthalmol. 2006 Jun 5;6:22. doi: 10.1186/1471-2415-6-22.

Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Clin Microbiol Rev. 2003 Oct;16(4):569-96. doi: 10.1128/CMR.16.4.569-596.2003.

Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?

Br J Ophthalmol. 1999 May;83(5):622-7. doi: 10.1136/bjo.83.5.622.

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.

Clin Pharmacokinet. 1999 Feb;36(2):127-43. doi: 10.2165/00003088-199936020-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验